BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bertini E, Biancalana V, Bolino A, Buj Bello A, Clague M, Guicheney P, Jungbluth H, Kress W, Musaro' A, Nandurkar H, Pirola L, Romero N, Senderek J, Suter U, Sewry C, Tronchere H, Wallgren-Pettersson C, Wishart MJ, Laporte J. 118th ENMC International Workshop on Advances in Myotubular Myopathy. 26-28 September 2003, Naarden, The Netherlands. (5th Workshop of the International Consortium on Myotubular Myopathy). Neuromuscul Disord 2004;14:387-96. [PMID: 15145343 DOI: 10.1016/j.nmd.2004.04.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Laing NG, Sewry CA, Lamont P. Congenital myopathies. Myopathies. Elsevier; 2007. pp. 1-33. [DOI: 10.1016/s0072-9752(07)86001-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
2 Trump N, Cullup T, Verheij JB, Manzur A, Muntoni F, Abbs S, Jungbluth H. X-linked myotubular myopathy due to a complex rearrangement involving a duplication of MTM1 exon 10. Neuromuscul Disord 2012;22:384-8. [PMID: 22153990 DOI: 10.1016/j.nmd.2011.11.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
3 Michell RH, Heath VL, Lemmon MA, Dove SK. Phosphatidylinositol 3,5-bisphosphate: metabolism and cellular functions. Trends Biochem Sci 2006;31:52-63. [PMID: 16364647 DOI: 10.1016/j.tibs.2005.11.013] [Cited by in Crossref: 169] [Cited by in F6Publishing: 165] [Article Influence: 9.9] [Reference Citation Analysis]
4 Shichiji M, Biancalana V, Fardeau M, Hogrel JY, Osawa M, Laporte J, Romero NB. Extensive morphological and immunohistochemical characterization in myotubular myopathy. Brain Behav 2013;3:476-86. [PMID: 24381816 DOI: 10.1002/brb3.147] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
5 Vandersmissen I, Biancalana V, Servais L, Dowling J, Vander Stichele G, Van Rooijen S, Thielemans L. An integrated modelling methodology for estimating the prevalence of centronuclear myopathy. Neuromuscular Disorders 2018;28:766-77. [DOI: 10.1016/j.nmd.2018.06.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
6 Jungbluth H, Wallgren-pettersson C, Laporte JF. 164th ENMC International workshop: 6th workshop on centronuclear (myotubular) myopathies, 16–18th January 2009, Naarden, The Netherlands. Neuromuscular Disorders 2009;19:721-9. [DOI: 10.1016/j.nmd.2009.06.373] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
7 Dowling JJ, Gibbs EM, Feldman EL. Membrane traffic and muscle: lessons from human disease. Traffic 2008;9:1035-43. [PMID: 18266915 DOI: 10.1111/j.1600-0854.2008.00716.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
8 Jungbluth H, Zhou H, Sewry CA, Robb S, Treves S, Bitoun M, Guicheney P, Buj-Bello A, Bönnemann C, Muntoni F. Centronuclear myopathy due to a de novo dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul Disord 2007;17:338-45. [PMID: 17376685 DOI: 10.1016/j.nmd.2007.01.016] [Cited by in Crossref: 79] [Cited by in F6Publishing: 74] [Article Influence: 5.3] [Reference Citation Analysis]
9 Amburgey K, Lawlor MW, Del Gaudio D, Cheng YW, Fitzpatrick C, Minor A, Li X, Aughton D, Das S, Beggs AH, Dowling JJ. Large duplication in MTM1 associated with myotubular myopathy. Neuromuscul Disord 2013;23:214-8. [PMID: 23273872 DOI: 10.1016/j.nmd.2012.11.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
10 Schessl J, Medne L, Hu Y, Zou Y, Brown MJ, Huse JT, Torigian DA, Jungbluth H, Goebel HH, Bönnemann CG. MRI in DNM2-related centronuclear myopathy: evidence for highly selective muscle involvement. Neuromuscul Disord 2007;17:28-32. [PMID: 17134899 DOI: 10.1016/j.nmd.2006.09.013] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 3.3] [Reference Citation Analysis]
11 Jungbluth H, Wallgren-Pettersson C, Laporte J. Centronuclear (myotubular) myopathy. Orphanet J Rare Dis 2008;3:26. [PMID: 18817572 DOI: 10.1186/1750-1172-3-26] [Cited by in Crossref: 192] [Cited by in F6Publishing: 169] [Article Influence: 13.7] [Reference Citation Analysis]
12 Cox K, Gattas M, Harvey P, Dolphin C, Friend K, Yu S. X-linked myotubular myopathy: mutation R69C identified in a family with multiple neonatal deaths. Clin Genet 2005;67:441-2. [PMID: 15811014 DOI: 10.1111/j.1399-0004.2005.00433.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
13 Manta P, Mamali I, Zambelis T, Aquaviva T, Kararizou E, Kalfakis N. Immunocytochemical study of cytoskeletal proteins in centronuclear myopathies. Acta Histochem 2006;108:271-6. [PMID: 16893562 DOI: 10.1016/j.acthis.2006.05.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
14 Robb SA, Sewry CA, Dowling JJ, Feng L, Cullup T, Lillis S, Abbs S, Lees MM, Laporte J, Manzur AY, Knight RK, Mills KR, Pike MG, Kress W, Beeson D, Jungbluth H, Pitt MC, Muntoni F. Impaired neuromuscular transmission and response to acetylcholinesterase inhibitors in centronuclear myopathies. Neuromuscul Disord 2011;21:379-86. [PMID: 21440438 DOI: 10.1016/j.nmd.2011.02.012] [Cited by in Crossref: 75] [Cited by in F6Publishing: 61] [Article Influence: 6.8] [Reference Citation Analysis]
15 D'Amico A, Bertini E. Congenital myopathies. Curr Neurol Neurosci Rep 2008;8:73-9. [PMID: 18367042 DOI: 10.1007/s11910-008-0012-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]